TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | 7 | 14 | 28 | 14 | 45 | 67 | 29 |
P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||
S | %ret | 1 | 1 | 2 | -1 | 3 | 20 | 32 | 42 | 48 | 24 |
S | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/6/21 16:25 | 12/2/21 | SELB | Selecta Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Desilva Nishan M | MA | D | P | 21 | 2.96 | 0 | 7 | New | 7 | D | |||||||||||||||
5/14/15 17:39 | 5/12/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Desilva Nishan M | CA | O | VP,Finan | M.dm | 2,404 | 35.17 | 33 | 68 | 22 | D | 214 | 31 | 51 | 48 | 8 | -6 | 5 | 4 | 0 | 3 | 12 | 14 | 18 | 39 | |
5/14/15 17:39 | 5/12/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Desilva Nishan M | CA | O | VP,Finan | S.dm | -5,737 | 83.91 | 33 | -68 | -75 | 22 | D | 214 | 31 | 51 | 48 | 8 | -6 | 5 | 4 | 0 | 3 | 12 | 14 | 18 | 39 |
2/11/15 20:06 | 2/10/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Desilva Nishan M | CA | O | VP,Corpo | S.d | -130 | 56.34 | 15 | -2 | -9 | 22 | D | 172 | -10 | 5 | 4 | 7 | 3 | -1 | 0 | -1 | 2 | 28 | 49 | 66 | 56 |
7/1/13 15:27 | 6/28/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Desilva Nishan M | CA | O | VP,Corpo | P | 3 | 17.36 | 11 | 0 | 1 | 16 | D | 218 | 145 | 74 | 41 | 34 | 17 | 16 | 4 | 7 | 14 | 28 | 14 | 45 | 67 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |